{{medical}}
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 443508421
| IUPAC_name = (6''R'',7''R'')-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl}-8-oxo-7-[(1''H''-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
| image = Cefazolin.svg
| image2 = Cefazolin ball-and-stick.png
<!--Clinical data-->
| tradename = Ancef, Cefacidal, Cefamezin, Cefrina, Elzogram, Faxilen, Gramaxin, Kefzol, Kefol, Kefzolan, Kezolin, Novaporin, Reflin, Zinol Zolicef
| Drugs.com = {{drugs.com|monograph|ancef}}
| pregnancy_AU = B1
| pregnancy_US = B
| legal_status = Rx-only
| routes_of_administration = 静脉注射, 肌肉注射
<!--Pharmacokinetic data-->
| bioavailability = NA
| metabolism = ?
| elimination_half-life = 1.8 小时(静注)<br>2 小时(肌注)
| excretion = [[肾脏|肾脏]], 不变
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 25953-19-9
| ATC_prefix = J01
| ATC_suffix = DB04
| ATC_supplemental = {{ATCvet|J51|DB04}}
| PubChem = 33255
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01327
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 30723
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = IHS69L0Y4T
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02299
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 474053
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1435
<!--Chemical data-->
| C=14 | H=14 | N=8 | O=4 | S=3
| molecular_weight = 454.51 g/mol
| smiles = O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)Cn3nnnc3)CSc4nnc(s4)C)C(=O)O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C14H14N8O4S3/c1-6-17-18-14(29-6)28-4-7-3-27-12-9(11(24)22(12)10(7)13(25)26)16-8(23)2-21-5-15-19-20-21/h5,9,12H,2-4H2,1H3,(H,16,23)(H,25,26)/t9-,12-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = MLYYVTUWGNIJIB-BXKDBHETSA-N
}}

<!-- Definition and medical uses -->
'''頭孢唑林'''（{{lang-en|Cefazolin}}，cefazoline 或 cephazolin），是一種用於治療多種[[病原細菌|病原細菌]]的[[抗細菌藥|抗細菌藥]]<ref name=AHFS2016>{{cite web|title=Cefazolin Sodium|url=https://www.drugs.com/monograph/cefazolin-sodium.html|publisher=The American Society of Health-System Pharmacists|accessdate=8 December 2016|archive-date=2019-04-27|archive-url=https://web.archive.org/web/20190427094655/https://www.drugs.com/monograph/cefazolin-sodium.html|dead-url=no}}</ref>，尤其針對[[蜂窩組織炎|蜂窩組織炎]]、[[泌尿道感染|泌尿道感染]]、[[肺炎|肺炎]]、[[心內膜炎|心內膜炎]]、[[敗血性關節炎|敗血性關節炎]]及{{le|膽道發炎|biliary tract infections}}等疾病<ref name=AHFS2016/>，也可用來預防手術前或手術中{{le|B群鏈球菌|group B streptococcal disease}}感染<ref name=AHFS2016/>。本品通常經[[肌肉注射|肌肉注射]]或是[[靜脈注射|靜脈注射]]給藥<ref name=AHFS2016/>。
目前該藥有下列幾種廠牌名稱：Ancef®、Cefacidal®、Cefamezin®、Cefrina®、Elzogram®、Faxilen®、Gramaxin®、Kefazol®、Kefol®、Kefzol®、Kefzolan®、Kezolin®、Novaporin®與Zolicef®。

<!-- Side effects and mechanism -->
常見的副作用有[[腹瀉|腹瀉]]、嘔吐、[[念珠菌症|念珠菌感染]]和[[過敏|過敏]]<ref name=AHFS2016/>。對[[青黴素|青黴素]]有[[過敏性休克|過敏性休克]]病史的患者不建議使用<ref name=WHO2008>{{cite book|title=WHO Model Formulary 2008|date=2009|publisher=World Health Organization|isbn=9789241547659|page=106|url=http://apps.who.int/medicinedocs/documents/s16879e/s16879e.pdf|accessdate=8 December 2016|archiveurl=https://web.archive.org/web/20161213060118/http://apps.who.int/medicinedocs/documents/s16879e/s16879e.pdf|archivedate=2016-12-13|dead-url=no}}</ref>。本品在[[妊娠|懷孕]]及[[母乳哺育|餵母乳]]期間給藥相對安全<ref name=AHFS2016/><ref name=Ric2015>{{cite book |last1=Hamilton |first1=Richart |title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=84}}</ref>。頭孢唑林的運作方式為破壞細菌的[[細胞壁|細胞壁]]；此藥屬於第一代的[[頭孢菌素|頭孢菌素]]<ref name=AHFS2016/>。

<!-- History, society and culture -->
1967年，頭孢唑啉獲得專利，在1971年上市<ref>{{cite book|last1=Fischer|first1=Janos|last2=Ganellin|first2=C. Robin|title=Analogue-based Drug Discovery|date=2006|publisher=John Wiley & Sons|isbn=9783527607495|page=493|url=https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA493|language=en|archiveurl=https://web.archive.org/web/20170910171829/https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA493|archivedate=2017-09-10|access-date=2020-12-31|dead-url=no}}</ref>。此藥名列[[世界衛生組織基本藥物標準清單|世界衛生組織基本藥物標準清單]]，意即認可為[[醫療系統|醫療系統]]中最有效且安全的必備藥物<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|publisher=World Health Organization|accessdate=8 December 2016|date=April 2015|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=2016-12-13|dead-url=no}}</ref>，並已有[[通用名藥物|學名藥]]問世<ref name=AHFS2016/>。[[開發中國家|開發中國家]]的每日劑量批發價約為 1.21 - 1.41 美元<ref name=ERC2014>International Drug Price Indicator Guide</ref>。在美國，一組療程的藥費在 25 - 50 美元之間<ref name=Ric2015/>。

==參考文獻==
{{Reflist}}

==外部連結==
* {{en icon}}[http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682731.html MedlinePlus Drug Information: Cefazolin Sodium Injection.]{{Wayback|url=http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682731.html |date=20080227025444 }}
* {{en icon}}[http://www.ehs.lilly.com/msds/msds_cefazolin_sodium.html Eli Lilly Cefazolin Sodium Material Safety Data Sheet.]{{Wayback|url=http://www.ehs.lilly.com/msds/msds_cefazolin_sodium.html |date=20071012005853 }}

{{细胞壁破坏性抗生素}}

[[Category:頭孢菌素|Category:頭孢菌素]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]
[[Category:四唑|Category:四唑]]
[[Category:噻二唑|Category:噻二唑]]